SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.58%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$104M
AUM Growth
+$104M
(-6.2%)
Cap. Flow
-$8.43M
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
75.87%
Holding
124
New
25
Increased
12
Reduced
14
Closed
41
Top Buys
| 1 |
Biogen
BIIB
|
$17.7M |
| 2 |
AstraZeneca
AZN
|
$10.9M |
| 3 |
Reviva Pharmaceuticals
RVPH
|
$3.13M |
| 4 |
XWELL
XWEL
|
$2.57M |
| 5 |
CEL-SCI Corp
CVM
|
$2.36M |
Top Sells
| 1 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$6.76M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$4.25M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$4.12M |
| 4 |
SPI
SPI Energy Co., Ltd. Ordinary Shares
SPI
|
$3.07M |
| 5 |
Rockwell Medical
RMTI
|
$3.01M |
Sector Composition
| 1 | Healthcare | 88.71% |
| 2 | Industrials | 3.58% |
| 3 | Technology | 1.08% |
| 4 | Consumer Discretionary | 0.7% |
| 5 | Consumer Staples | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $28.6M | 5.49% | 116,970 +72,434 | +163% | +$17.7M |
|
|
2
AstraZeneca
AZN
$248B
| $18.2M | 3.5% | 365,000 +217,055 | +147% | +$10.9M |
|
3
Moderna
MRNA
$9.37B
| $12.1M | 2.32% | 116,000 -5,975 | -5% | -$624K |
|
|
4
XWELL
XWEL
$6.36M
| $3.99M | 0.77% | 3,354,960 +2,163,727 | +182% | +$2.57M |
|
|
5
CEL-SCI Corp
CVM
$71.8M
| $3.62M | 0.69% | 310,155 +202,277 | +188% | +$2.36M |
|
|
6
Reviva Pharmaceuticals
RVPH
$30.6M
| $3.13M | 0.6% | +358,300 | New | +$3.13M |
|
7
Inovio Pharmaceuticals
INO
$126M
| $2.53M | 0.48% | 285,388 +160,504 | +129% | +$1.42M |
|
8
Pulmatrix
PULM
$18M
| $2.35M | 0.45% | 1,975,309 +234,646 | +13% | +$279K |
|
|
AFIB
9
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $2.23M | 0.43% | 77,500 +27,844 | +56% | +$802K |
|
|
NMRD
10
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
| $1.86M | 0.36% | 494,297 -119,468 | -19% | -$451K |
|
|
TRIL
11
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.77M | 0.34% | +119,996 | New | +$1.77M |
|
12
Globus Maritime Ltd
GLBS
$21.4M
| $1.66M | 0.32% | +290,535 | New | +$1.66M |
|
13
Daxor
DXR
$54.6M
| $1.61M | 0.31% | 128,398 +5,992 | +5% | +$74.9K |
|
14
SuperCom
SPCB
$39.7M
| $1.52M | 0.29% | 1,480,000 | – | – |
|
|
TCDA
15
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.41M | 0.27% | +200,437 | New | +$1.41M |
|
|
MRNS
16
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.23M | 0.24% | +100,800 | New | +$1.23M |
|
17
Astrotech Corp
ASTC
$8.72M
| $1.12M | 0.22% | +634,297 | New | +$1.12M |
|
|
ITCI
18
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.11M | 0.21% | 35,000 -80,000 | -70% | -$2.54M |
|
|
HMCOU
19
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
| $1.05M | 0.2% | +95,050 | New | +$1.05M |
|
20
Cellectar Biosciences
CLRB
$15.5M
| $1.04M | 0.2% | +499,030 | New | +$1.04M |
|
|
ODT
21
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $921K | 0.18% | 47,945 -30,333 | -39% | -$583K |
|
22
Aurinia Pharmaceuticals
AUPH
$1.58B
| $774K | 0.15% | 55,943 +42,399 | +313% | +$587K |
|
|
MTVA
23
MetaVia Inc. Common Stock
MTVA
$15.3M
| $748K | 0.14% | 142,400 -40,143 | -22% | -$211K |
|
|
KNDI
24
Kandi Technologies Group
KNDI
$120M
| $729K | 0.14% | +105,714 | New | +$729K |
|
|
MRTX
25
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $659K | 0.13% | +3,000 | New | +$659K |
|